According to Zacks, “RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. RTI Surgical Inc., formerly known as RTI Biologics, Inc., is headquartered in Alachua, Fla. “
Separately, Craig Hallum downgraded RTI Surgical from a buy rating to a hold rating and lowered their price target for the stock from $6.00 to $4.00 in a report on Thursday, July 28th.
RTI Surgical (NASDAQ:RTIX) opened at 3.11 on Wednesday. The company has a 50 day moving average price of $3.20 and a 200-day moving average price of $3.63. The company has a market capitalization of $179.67 million, a P/E ratio of 43.80 and a beta of 1.57. RTI Surgical has a 52 week low of $2.81 and a 52 week high of $5.72.
RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Wednesday, July 27th. The company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of $0.03 by $0.08. The company earned $67.60 million during the quarter, compared to the consensus estimate of $66.52 million. RTI Surgical had a net margin of 2.80% and a return on equity of 6.51%. The company’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.04 EPS. On average, equities analysts anticipate that RTI Surgical will post $0.10 earnings per share for the current fiscal year.
Large investors have recently made changes to their positions in the company. Schwab Charles Investment Management Inc. increased its stake in shares of RTI Surgical by 19.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 224,600 shares of the company’s stock valued at $807,000 after buying an additional 36,002 shares during the period. Numeric Investors LLC boosted its position in RTI Surgical by 14.0% in the second quarter. Numeric Investors LLC now owns 68,196 shares of the company’s stock valued at $245,000 after buying an additional 8,400 shares in the last quarter. KCG Holdings Inc. purchased a new position in RTI Surgical during the second quarter valued at $108,000. State Street Corp boosted its position in RTI Surgical by 1.4% in the second quarter. State Street Corp now owns 964,124 shares of the company’s stock valued at $3,459,000 after buying an additional 13,223 shares in the last quarter. Finally, Spark Investment Management LLC boosted its position in RTI Surgical by 16.2% in the second quarter. Spark Investment Management LLC now owns 216,100 shares of the company’s stock valued at $775,000 after buying an additional 30,100 shares in the last quarter. Institutional investors own 78.97% of the company’s stock.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.